Authors


Stephen Scheinthal, DO, DFACN, DFAPA, CS

Latest:

Screening for Alzheimer Disease: Facilitating an Early Diagnosis for Prompt Intervention

In this episode of MEDcast, expert geriatric psychiatrists explore the urgent need for effective diagnostic methods that can detect Alzheimer’s disease at an early stage. We will discuss blood-based biomarkers and other advancements that can help screen Alzheimer’s disease non-invasively and early in the disease course.


Jose Terencio, PhD

Latest:

Overviewing Preliminary Data of ABvac40, a Vaccine for Alzheimer Disease: Jose Terencio, PhD

The vice president of Innovation and New Technologies at Grifols provided perspective on the interim phase 2 findings of ABvac40, a vaccine in development for patients with Alzheimer disease. [WATCH TIME: 3 minutes]


Lauren B. Krupp, MD

Latest:

The Future of Pediatric Multiple Sclerosis

Tanuja Chitnis, MD and Lauren B. Krupp, MD give insight into the future of pediatric multiple sclerosis by discussing unmet needs and advice for community neurologists.


Sana Syed, MBBS, MPH

Latest:

Alternative Career Paths: Clinical Care Through Clinical Research

For women, the decision to opt for an unconventional career path can be inspired by conflicting responsibilities and balancing life with work. But, as Sana Syed, MD, MPH, explains, following your passion is still an achievable dream despite these challenges.


Allegheny Health Network

Latest:

Maximal Results With Minimal Invasion: Enhancing AHN Patient Outcomes With Advanced Spine Surgery Techniques

AHN Neuroscience Institute is using advanced, minimally invasive spinal surgery techniques to treat complex spine conditions, offering faster recovery, smaller incisions, and improved patient outcomes.


Nina Miolane, PhD

Latest:

Women's Neurology: Perspectives from the Ann S. Bowers Women's Brain Health Initiative

Nina Miolane, PhD, and Amy Kuceyeski, PhD, the codirectors of the Ann S. Bowers Women's Brain Health Initiative AI Core, provided their commentary on the challenges and progress made in women’s neurology.


Charlene Gamadelo, MD

Latest:

Insomnia Treatment Selection: DORA

Charlene Gamaldo, MD, discusses patient criteria for selecting a dual orexin receptor agonist (DORA) for insomnia treatment.


Süleyman Güler, MD

Latest:

Medical Gaslighting: Multiple Sclerosis’ Dirty Little Secret?

The effect of gaslighting on patients can result in serious harms, and although it is potentially common in the MS care continuum, whether it is deliberate or an institutional problem, it must be called out by providers.


Carolina Ferreira Atuesta, MD, MSc

Latest:

Post-Stroke Seizure Predictive Models, SeLECT Model: Carolina Ferreira Atuesta, MD, MSc

The scientific researcher and clinical manager, Icahn School of Medicine at Mount Sinai, spoke about the clinical models used to predict seizures in poststroke patients. [WATCH TIME: 4 minutes]


Jennifer Gudeman, PharmD

Latest:

Understanding Treatment Benefit of Once-Nightly Sodium Oxybate in Narcolepsy Types 1 and 2: Jennifer Gudeman, PharmD

The senior vice president of medical and clinical affairs for Avadel Pharmaceuticals provided commentary on recently published research supporting once-nightly sodium oxybate (Lumryz) in narcolepsy regardless of the subtype. [WATCH TIME: 5 minutes]


William Noah, MD

Latest:

Improving PAP Adherence in Younger Patients With OSA: William Noah, MD

The director and founder of the Sleep Centers of Middle Tennessee discussed trends in positive airway pressure adherence that his center’s research has revealed.


Lee Shwamm, MD

Latest:

Stroke Prevention and Atrial Fibrillation Management, Thoughts From STROKE-AF Study: Lee Shwamm, MD

The professor of neurology at Harvard Medical School spoke at the 2023 ISC Conference about highlights from the STROKE-AF study after a 3-year follow-up. [WATCH TIME: 5 minutes]


Amit Rakhit, MD

Latest:

Mechanism of Stem Cell Therapy Bemdaneprocel for Parkinson Disease: Amit Rakhit, MD

The chief medical officer and chief development officer at BlueRock Therapeutics discussed the promise behind bemdaneprocel and its unique mechanism of action relative to other Parkinson disease treatments. [WATCH TIME: 3 minutes]


Lisa Merlin, MD

Latest:

Closing Thoughts on 2024 AUPN Annual Meeting

The meeting with the American Neurologic Association fosters collaboration, networking, and joint sessions, enhancing knowledge sharing among academic neurologists.


Allitia DiBernardo, MD

Latest:

Importance of Evaluating Real-World Populations in MS: Allitia DiBernardo, MD

The global head of medical affairs-neurology at Janssen Pharmaceutical provided background on the need for real-world studies and how they can accurately portray a disease community.


Mary Anne Meskis

Latest:

Advice for Managing Dravet Syndrome and LGS

Mary Anne Meskis; Tracy Dixon-Salazar, PhD; Kelly Knupp, MD; and Joseph E. Sullivan, MD, provide advice for physicians treating patients with Dravet syndrome or LGS.


Andreas Forsland

Latest:

Combining Brain-Computer Interface with Augmented Reality for Neurodegenerative Diseases: Andreas Forsland

The chief executive officer of Cognixion talked about the Cognixion ONE Axon, a wireless, wearable brain-computer interface that combines EEG technology with an augmented reality headset for patients with neurodegenerative diseases. [WATCH TIME: 4 minutes]


Katherine Podraza, MD, PhD

Latest:

Retinal Vasculature Changes in Migraine With Aura: Katherine Podraza, MD, PhD

The headache specialist at the Hartford Healthcare Headache Center discussed findings from a study that revealed altered retinal vasculature in individuals with migraine with aura, indicating potential retinal biomarkers for disease progression. [WATCH TIME: 4 minutes]


Crystal Sada

Latest:

Both Sides Now: The Before and After of CIDP’s Diagnostic Journey

Crystal, a patient living with chronic inflammatory demyelinating polyneuropathy and one of the faces of the Shining Through CIDP awareness campaign, discussed the diagnostic challenges associated with the rare disease.


Mark I. Boulos, MD, MSc, FRCP, CSCN

Latest:

2024 Clinical Preview for Emerging Trends in Sleep Disorders: Mark I. Boulos, MD, BSc, FRCP, CSCN, MSc

The associate professor, department of medicine, division of neurology, Institute of Medical Science, University of Toronto, shared his thoughts on potential therapies and expanding care options for sleep disorders in 2024. [WATCH TIME: 5 minutes]


Lucia Ricciardi, MD, PhD

Latest:

Multifaceted Approach to Managing Neuropsychiatric Symptoms of Parkinson Disease: Lucia Ricciardi, MD, PhD

The consultant neurologist and senior lecturer at St. Georges Hospital in London, explores the origins of common neuropsychiatric symptoms experienced by patients with Parkinson disease and how they may be exasperated. [WATCH TIME: 4 minutes]


Emilio Portaccio, MD

Latest:

Improving MS Management Through Early Intervention and Precision Medicine: Emilio Portaccio, MD

The professor of neurology at University of Florence talked about how early intervention, broader assessment tools, and personalized approaches are essential for effectively managing multiple sclerosis. [WATCH TIME: 4 minutes]


Noah Stansfield

Latest:

What to Expect at MDA’s 2025 Clinical and Scientific Conference: Barry J. Byrne, MD, PhD

The chief medical advisor at the Muscular Dystrophy Association shared key highlights of what attendees can expect at the 2025 MDA Clinical and Scientific Conference. [WATCH TIME: 4 minutes]


Jihan A. Grant, MD

Latest:

Search for Targeted Therapies for Primary Headaches Beyond Migraine: Jihan A. Grant, MD

The director of headache medicine at The Mount Sinai Hospital talked about the often-overlooked realm of primary headaches beyond migraines as well as the importance of developing targeted treatments and increasing understanding of their pathophysiology. [WATCH TIME: 7 minutes]


Katherine Turk, MD

Latest:

Improving Diagnosis, Screening Patients More Efficiently in Alzheimer Disease: Katherine Turk, MD

The behavioral neurologist at VA Boston Healthcare System talked about screening patients for mild cognitive impairment to improve diagnosis in Alzheimer disease at the 2023 AAN Annual Meeting. [WATCH TIME: 5 minutes]


Aaron Miller, MD, FAAN

Latest:

Practice Pearls for Management of NMOSD

Experts in neurology discuss immune tolerance as an alternative strategy and share practice pearls for approaching treatment of NMOSD.


Bradley McDaniels, PhD, CRC

Latest:

Tools for Cultivating Meaning This Holiday Season

What excites you? What awakens your sense of purpose? What gives your life meaning? Bradley McDaniels, PhD, CRC, explores the importance of meaning in one's life.


Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN

Latest:

AUPN Leadership Minute Episode 28: Leadership to Effect Change

Episode 28 of the AUPN Leadership Minute features Donald S. Higgins, MD, of the VHA; and Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN, of University of Oxford. [WATCH TIME: 5 minutes]


Annette Okai, MD, FAAN

Latest:

Getting Up to Speed on the Evolving Landscape of Multiple Sclerosis: Annette Okai, MD

The medical director of the North Texas Institute of Neurology and Headache offered an overview of the State of the Science Summit that was held on July 21, 2022, with a variety of expert clinicians in MS care. [WATCH TIME: 3 minutes]


Fiona Gupta, MD

Latest:

Dyskinesia: Importance of Giving Patients More Good “On- Time" In Parkinson’s Disease

Drs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.

© 2025 MJH Life Sciences

All rights reserved.